Grants per year
Personal profile
Certifications and Licenses
| Internal Medicine | |
| Hematology & Oncology |
Training Experience
| 2010 | Residency, University of Chicago |
| 2013 | Fellowship, Stanford University Hospitals |
Education/Academic qualification
Medicine, MD, University of Chicago
… → 2007
Fingerprint
Dive into the research topics where Shira Naomi Dinner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #GS-US-546-5857: A Phase 3, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination with Azacitidine versus Physician's Choice of Venetoclax in Combination with Azacitidine or Intensive Chemotherapy in Previously
Pharmaceutical Research Associates, Inc., Gilead Sciences, Inc.
1/10/22 → 1/10/25
Project: Research project
-
Dr. Dinner - Alliance Foundation Trials, LLC Contract 2019-2020
Alliance Foundation Trials, LLC
1/1/21 → 12/31/22
Project: Research project
-
Prot #5F9009: ENHANCE: A Randomized, Double-blind, Multicenter Study Comparing Magrolimab in Combination with Azacitidine versus Azacitidine Plus Placebo in Treatment-naïve Patients with Higher Risk Myelodysplastic Syndrome
ICON Clinical Research, LLC, Forty Seven, Inc.
8/18/20 → 8/18/23
Project: Research project
-
Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors
Numan, Y., Abdel Rahman, Z., Grenet, J., Boisclair, S., Bewersdorf, J. P., Collins, C., Barth, D., Fraga, M., Bixby, D. L., Zeidan, A. M., Yilmaz, M., Desai, P., Mannis, G., Deutsch, Y. E., Abaza, Y., Dinner, S., Frankfurt, O., Litzow, M., Al-Kali, A., Foran, J. M. & 5 others, , Mar 1 2022, In: American Journal of Hematology. 97, 3, p. 322-328 7 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Myelodysplastic Syndromes, Version 3.2022: Featured Updates to the NCCN Guidelines
Greenberg, P. L., Stone, R. M., Al-Kali, A., Bennett, J. M., Borate, U., Brunner, A. M., Chai-Ho, W., Curtin, P., De Castro, C. M., Joachim Deeg, H., DeZern, A. E., Dinner, S., Foucar, C., Gaensler, K., Garcia-Manero, G., Griffiths, E. A., Head, D., Jonas, B. A., Keel, S., Madanat, Y. & 15 others, , Feb 2022, In: JNCCN Journal of the National Comprehensive Cancer Network. 20, 2, p. 106-117 12 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival
Badar, T., Atallah, E., Shallis, R. M., Goldberg, A. D., Patel, A., Abaza, Y., Bewersdorf, J. P., Saliba, A. N., Correia, G. S. D. C., Murthy, G., Duvall, A., Burkart, M., Stahl, M., Liu, Y., Dinner, S., Palmisiano, N., Litzow, M. R. & Foran, J. M., Jul 2022, In: American Journal of Hematology. 97, 7, p. E232-E235Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
Acute lymphoblastic leukemia, version 2.2021
Brown, P. A., Shah, B., Advani, A., Aoun, P., Boyer, M. W., Burke, P. W., DeAngelo, D. J., Dinner, S., Fathi, A. T., Gauthier, J., Jain, N., Kirby, S., Liedtke, M., Litzow, M., Logan, A., Luger, S., Maness, L. J., Massaro, S., Mattison, R. J., May, W. & 12 others, , Sep 2021, In: JNCCN Journal of the National Comprehensive Cancer Network. 19, 9, p. 1079-1109 31 p.Research output: Contribution to journal › Review article › peer-review
Open Access6 Scopus citations -
Inhibitory effects of Tomivosertib in acute myeloid leukemia
Suarez, M., Blyth, G. T., Mina, A. A., Kosciuczuk, E. M., Dolniak, B., Dinner, S., Altman, J. K., Eklund, E. A., Saleiro, D., Beauchamp, E. M. & Platanias, L. C., May 11 2021, In: Oncotarget. 12, 10, p. 955-966 12 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations